Enhancing the treatment potential of IL-17 antagonism in lupus nephritis: finding the right partner
The treatment of lupus nephritis (LN) has been benefiting from biologics targeting immune cells and cytokines. IL-17 antagonists have been investigated for their potential in LN treatment, with mixed results from case reports and randomized controlled …